New drugs and dosage forms.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002990:Clobetasol / Q000627:therapeutic use; D004304:Dosage Forms; D004338:Drug Combinations; D005464:Fluorobenzenes / Q000627:therapeutic use; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007093:Imidazoles / Q000627:therapeutic use; D008687:Metformin / Q000008:administration & dosage; D004364:Pharmaceutical Preparations / Q000008:administration & dosage; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones; D013844:Thiazoles / Q000008:administration & dosage; D014227:Triazines; D014481:United States; D014486:United States Food and Drug Administration; D000069058:Vardenafil Dihydrochloride
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004304:Dosage Forms; D004338:Drug Combinations; D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007004:Hypoglycemic Agents; D007093:Imidazoles; D004364:Pharmaceutical Preparations; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011743:Pyrimidines; D013449:Sulfonamides; D013450:Sulfones; D013844:Thiazoles; D014227:Triazines; C471074:rosiglitazone-metformin combination; D000069058:Vardenafil Dihydrochloride; D000068718:Rosuvastatin Calcium; D008687:Metformin; D002990:Clobetasol